BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 23893409)

  • 21. Stable genetic alterations of β-catenin and ROR2 regulate the Wnt pathway, affect the fate of MSCs.
    Cai SX; Liu AR; He HL; Chen QH; Yang Y; Guo FM; Huang YZ; Liu L; Qiu HB
    J Cell Physiol; 2014 Jun; 229(6):791-800. PubMed ID: 24590964
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cripto-1 contributes to stemness in hepatocellular carcinoma by stabilizing Dishevelled-3 and activating Wnt/β-catenin pathway.
    Lo RC; Leung CO; Chan KK; Ho DW; Wong CM; Lee TK; Ng IO
    Cell Death Differ; 2018 Aug; 25(8):1426-1441. PubMed ID: 29445127
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Wnt/β-catenin signaling via Axin2 is required for myogenesis and, together with YAP/Taz and Tead1, active in IIa/IIx muscle fibers.
    Huraskin D; Eiber N; Reichel M; Zidek LM; Kravic B; Bernkopf D; von Maltzahn J; Behrens J; Hashemolhosseini S
    Development; 2016 Sep; 143(17):3128-42. PubMed ID: 27578179
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ror2, a Developmentally Regulated Kinase, Is Associated With Tumor Growth, Apoptosis, Migration, and Invasion in Renal Cell Carcinoma.
    Yang CM; Ji S; Li Y; Fu LY; Jiang T; Meng FD
    Oncol Res; 2017 Jan; 25(2):195-205. PubMed ID: 28277191
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Wnt/β-Catenin Signaling Activation beyond Robust Nuclear β-Catenin Accumulation in Nondysplastic Barrett's Esophagus: Regulation via Dickkopf-1.
    Lyros O; Rafiee P; Nie L; Medda R; Jovanovic N; Otterson MF; Behmaram B; Gockel I; Mackinnon A; Shaker R
    Neoplasia; 2015 Jul; 17(7):598-611. PubMed ID: 26297437
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Canonical and non-canonical Wnt signaling are simultaneously activated by Wnts in colon cancer cells.
    Flores-Hernández E; Velázquez DM; Castañeda-Patlán MC; Fuentes-García G; Fonseca-Camarillo G; Yamamoto-Furusho JK; Romero-Avila MT; García-Sáinz JA; Robles-Flores M
    Cell Signal; 2020 Aug; 72():109636. PubMed ID: 32283254
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition by chondroitin sulfate E can specify functional Wnt/β-catenin signaling thresholds in NIH3T3 fibroblasts.
    Willis CM; Klüppel M
    J Biol Chem; 2012 Oct; 287(44):37042-56. PubMed ID: 22915582
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Orphan receptor kinase ROR2 is expressed in the mouse uterus.
    Hatta K; Chen Z; Carter AL; Leno-Durán E; Zhang J; Ruiz-Ruiz C; Olivares EG; MacLeod RJ; Croy BA
    Placenta; 2010 Apr; 31(4):327-33. PubMed ID: 20149452
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic significance of Ror2 and Wnt5a expression in medulloblastoma.
    Lee SE; Lim SD; Kang SY; Suh SB; Suh YL
    Brain Pathol; 2013 Jul; 23(4):445-53. PubMed ID: 23278988
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spinal Wnt5a Plays a Key Role in Spinal Dendritic Spine Remodeling in Neuropathic and Inflammatory Pain Models and in the Proalgesic Effects of Peripheral Wnt3a.
    Simonetti M; Kuner R
    J Neurosci; 2020 Aug; 40(35):6664-6677. PubMed ID: 32616667
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Niclosamide suppresses cancer cell growth by inducing Wnt co-receptor LRP6 degradation and inhibiting the Wnt/β-catenin pathway.
    Lu W; Lin C; Roberts MJ; Waud WR; Piazza GA; Li Y
    PLoS One; 2011; 6(12):e29290. PubMed ID: 22195040
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Wnt3a suppresses Wnt/β-catenin signaling and cancer cell proliferation following serum deprivation.
    He Q; Yan H; Wo D; Liu J; Liu P; Zhang J; Li L; Zhou B; Ge J; Li H; Liu S; Zhu W
    Exp Cell Res; 2016 Feb; 341(1):32-41. PubMed ID: 26643293
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of Ror2 mediates invasive phenotypes in renal cell carcinoma.
    Rasmussen NR; Debebe Z; Wright TM; Brooks SA; Sendor AB; Brannon AR; Hakimi AA; Hsieh JJ; Choueiri TK; Tamboli P; Maranchie JK; Hinds P; Wallen EM; Simpson C; Norris JL; Janzen WP; Rathmell WK
    PLoS One; 2014; 9(12):e116101. PubMed ID: 25542006
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SOX9 regulates low density lipoprotein receptor-related protein 6 (LRP6) and T-cell factor 4 (TCF4) expression and Wnt/β-catenin activation in breast cancer.
    Wang H; He L; Ma F; Regan MM; Balk SP; Richardson AL; Yuan X
    J Biol Chem; 2013 Mar; 288(9):6478-87. PubMed ID: 23306204
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TRAF6 function as a novel co-regulator of Wnt3a target genes in prostate cancer.
    Aripaka K; Gudey SK; Zang G; Schmidt A; Åhrling SS; Österman L; Bergh A; von Hofsten J; Landström M
    EBioMedicine; 2019 Jul; 45():192-207. PubMed ID: 31262711
    [TBL] [Abstract][Full Text] [Related]  

  • 36. β-arrestin promotes Wnt-induced low density lipoprotein receptor-related protein 6 (Lrp6) phosphorylation via increased membrane recruitment of Amer1 protein.
    Kríz V; Pospíchalová V; Masek J; Kilander MB; Slavík J; Tanneberger K; Schulte G; Machala M; Kozubík A; Behrens J; Bryja V
    J Biol Chem; 2014 Jan; 289(2):1128-41. PubMed ID: 24265322
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hyperbaric oxygen promotes osteogenic differentiation of bone marrow stromal cells by regulating Wnt3a/β-catenin signaling--an in vitro and in vivo study.
    Lin SS; Ueng SW; Niu CC; Yuan LJ; Yang CY; Chen WJ; Lee MS; Chen JK
    Stem Cell Res; 2014 Jan; 12(1):260-74. PubMed ID: 24291646
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Wnt Signaling Inhibits Osteoclast Differentiation by Activating Canonical and Noncanonical cAMP/PKA Pathways.
    Weivoda MM; Ruan M; Hachfeld CM; Pederson L; Howe A; Davey RA; Zajac JD; Kobayashi Y; Williams BO; Westendorf JJ; Khosla S; Oursler MJ
    J Bone Miner Res; 2016 Jan; 31(1):65-75. PubMed ID: 26189772
    [TBL] [Abstract][Full Text] [Related]  

  • 39. β-catenin-independent WNT signaling and Ki67 in contrast to the estrogen receptor status are prognostic and associated with poor prognosis in breast cancer liver metastases.
    Bleckmann A; Conradi LC; Menck K; Schmick NA; Schubert A; Rietkötter E; Arackal J; Middel P; Schambony A; Liersch T; Homayounfar K; Beißbarth T; Klemm F; Binder C; Pukrop T
    Clin Exp Metastasis; 2016 Apr; 33(4):309-23. PubMed ID: 26862065
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ROR2 deficit may induce the tetralogy of Fallot via down-regulating of β-catenin/SOX3/HSPA6 in vitro and in vivo.
    Guo R; Guo YZ; Zhou Q; Li G; Du Z; Shi Y; Xing Q
    J Cell Mol Med; 2023 Nov; 27(22):3539-3552. PubMed ID: 37749917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.